Residential anxiety and OCD treatment for Delray Beach — ERP density outpatient can't match.

RECO Immersive's residential program sits at 140 NE 4th Avenue in downtown Delray Beach — five minutes from Lake Ida, Pineapple Grove, and Osceola Park. For adults whose GAD, panic disorder, social anxiety, or OCD has not responded to outpatient CBT and SSRI trials, the residential level allows twice-daily exposure work, real-time ERP coaching, and rapid SSRI titration monitored with weekly GAD-7 and Y-BOCS. Step-down into on-site PHP and IOP keeps care continuous without relocation.

The RECO Immersive campus sits at 140 NE 4th Avenue, one block off Atlantic and a short walk from the Pineapple Grove arts district. For adults living in Lake Ida, Tropic Isle, Osceola Park, or the Beach District, entering residential anxiety treatment does not require flying to a distant facility or leaving a familiar city — the program is embedded in the same downtown blocks Delray Beach residents already navigate every day.

Why residential anxiety treatment works when outpatient hasn’t

Outpatient exposure-based CBT is the strongest-evidence modality for generalized anxiety disorder, panic disorder, social anxiety disorder, and OCD, but it depends on the client tolerating anxious arousal between weekly sessions and completing homework exposures without a clinician present. For severe presentations, the between-session interval is where treatment stalls — panic clients avoid interoceptive exposures, OCD clients neutralize ERP-triggered anxiety with subtle mental rituals, and socially anxious clients cancel graded assignments the morning they are due.

Residential collapses that interval. Structured exposures run twice daily with a clinician present to prevent escape and safety behaviors, and each exposure is followed by a processing group where anxious arousal is metabolized rather than avoided. For OCD specifically, ERP density in a residential setting produces measurable Y-BOCS reduction within two to four weeks — a trajectory that typically requires four to six months of weekly outpatient sessions to reach. That compression is the clinical case for residential care once adequate outpatient trials have already produced insufficient response.

OCD, panic, GAD, and social anxiety — disorder-specific tracks

The four primary anxiety disorders share SSRI-first pharmacology but require different exposure protocols, and Immersive stratifies programming by diagnosis rather than running a single generic anxiety group.

• OCD: Exposure and response prevention with structured hierarchies, response-prevention monitoring, and Y-BOCS scoring at intake, week two, week four, and discharge.
• Panic disorder: Interoceptive exposure — controlled hyperventilation, breath-holding, spinning, and cardiovascular exertion — paired with cognitive reappraisal of catastrophic misinterpretation of physical sensation.
• Social anxiety disorder: Graded in-vivo exposure hierarchies including behavioral experiments run outside the facility along Atlantic Avenue and in local retail and dining settings.
• Generalized anxiety disorder: Worry postponement, intolerance-of-uncertainty training, and metacognitive therapy targeting positive and negative beliefs about worry itself.

Clients also receive individual CBT twice weekly and, where indicated, Acceptance and Commitment Therapy for values-clarification and cognitive defusion work — components that reduce experiential avoidance across all four disorder classes and support long-term maintenance after discharge. Motivational interviewing is used with clients ambivalent about exposure, particularly early in the stay.

SSRI optimization at anxiety-effective doses

Anxiety disorders typically require higher SSRI dosing than the ranges commonly used for major depressive disorder. Sertraline for panic disorder or OCD often reaches 150 to 200 mg, escitalopram is pushed to 20 mg, paroxetine for OCD is dosed 40 to 60 mg, and fluvoxamine is titrated toward the upper end of its OCD indication. Many clients arrive on subtherapeutic regimens — 50 mg sertraline held for eighteen months, 10 mg escitalopram never increased — because outpatient titration was slow or was arrested at first partial response.

Residential structure allows faster, closely monitored titration with weekly GAD-7 and, where relevant, Y-BOCS tracking. Where SSRI monotherapy is insufficient after an adequate trial, augmentation follows evidence-based sequencing: buspirone for GAD, low-dose aripiprazole at 2 to 5 mg for treatment-resistant OCD, and short-course benzodiazepine bridging only where clinically indicated and with a documented taper plan at admission. Where multiple SSRI trials have already failed, an SNRI switch to venlafaxine XR at 225 mg is considered, or, for refractory OCD, clomipramine with baseline ECG and periodic level monitoring.

Comorbid depression and the sequenced treatment plan

Severe anxiety disorders present with comorbid major depressive disorder in roughly half of cases. The depression is often secondary — driven by years of functional impairment, avoidance, and social withdrawal — and improves substantially once anxiety severity meaningfully decreases. Immersive’s intake identifies the primary diagnosis using PHQ-9, GAD-7, Y-BOCS, and structured clinical interview, then sequences treatment accordingly rather than treating both diagnoses as equally weighted.

When PHQ-9 severity crosses 20 or active suicidal ideation is present, depression-specific interventions run in parallel — behavioral activation, and, where multiple SSRI trials have already failed, consultation regarding intranasal esketamine or an off-site intravenous ketamine protocol. For clients whose anxiety has masked bipolar features, mood stabilization with lithium or lamotrigine is initiated before aggressive SSRI titration to reduce the risk of iatrogenic switching into hypomania or a mixed state. Where trauma is central to the anxiety presentation, EMDR is added once acute symptom control has been established.

What to expect in the first 72 hours

Admission begins with a full psychiatric evaluation, medical history, and medication reconciliation. Clients meet the attending psychiatrist within 24 hours and receive baseline scoring on GAD-7, PHQ-9, Y-BOCS where OCD is suspected, and PCL-5 if trauma history is disclosed. Where adult ADHD is a differential, the ASRS is added. If alcohol or benzodiazepine use is present, CIWA-monitored withdrawal management is initiated before exposure work begins — untreated withdrawal will mimic and amplify anxiety symptoms and must be addressed first.

By day three, the primary therapist and psychiatrist have finalized the treatment plan: which exposures start when, whether current SSRI dosing is adequate or requires titration, and whether augmentation or a medication switch is warranted. Family contact is established with client consent, and outpatient step-down planning begins immediately. Most residential episodes run 30 to 60 days, with continuation into RECO Immersive’s partial hospitalization and intensive outpatient levels of care once acute symptom severity has decreased.

Insurance and admissions from Delray Beach

RECO Immersive is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, and Humana, and accepts most BCBS plans, including out-of-state policies. Verification of benefits typically completes within one business day, and admissions runs a medical-necessity determination against the plan’s residential mental health criteria before quoting an out-of-pocket estimate.

For Delray Beach residents, the campus is a five-to-ten-minute drive from most neighborhoods — Lake Ida, Pineapple Grove, Osceola Park, Tropic Isle, and the Beach District are all within a mile or two of the admissions entrance at 140 NE 4th Avenue. Admissions accepts calls seven days a week and can complete intake within 24 hours where clinically appropriate.

Serving residents of: Pineapple Grove, Lake Ida, Tropic Isle, Beach District, Osceola Park.